🔴 ICCM is trading 6.1% down today, extending a multi-day pullback after its post-reverse-split surge

ICCM is trading at $4.33 (down 6.1%), extending a sharp multi-day pullback as the stock consolidates following its recent post-reverse-split surge.

• Shares are giving back gains after extreme upside tied to a 1-for-30 reverse split and ProSense adoption following FDA breast-cancer authorization.
• There is no fresh company-specific news or rating changes today explicitly linked to the downward move.
• The price action reflects a period of consolidation in a weak market tape after significant recent volatility.